Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic experience with temocillin in peritonitis.

M Pfeiffer, R R Fock

    Drugs
    |January 1, 1985
    PubMed
    Summary

    Temocillin, a new beta-lactam antibiotic, showed high effectiveness in treating severe infections like peritonitis and abscesses in critically ill patients. This antibiotic was well-tolerated, with no adverse reactions observed during the study.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Native chromatome profiling reveals hundreds of metabolic enzymes in the nucleus across tissues.

    Nature communications·2026
    Same author

    Pressure-Tuned Quantum Criticality in the Locally Noncentrosymmetric Superconductor CeRh_{2}As_{2}.

    Physical review letters·2024
    Same author

    Recording the tactile P300 with the cEEGrid for potential use in a brain-computer interface.

    Frontiers in human neuroscience·2024
    Same author

    Exponential Bhatnagar-Gross-Krook integrator for multiscale particle-based kinetic simulations.

    Physical review. E·2022
    Same author

    [Immune reaction after penetrating keratoplasty depending on graft size and centration].

    Die Ophthalmologie·2022
    Same author

    [DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany - (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2)].

    Pneumologie (Stuttgart, Germany)·2020

    Area of Science:

    • Pharmacology
    • Infectious Diseases
    • Critical Care Medicine

    Background:

    • Severe infections pose significant challenges in critically ill patients.
    • Beta-lactam antibiotics are crucial for treating bacterial infections.
    • Temocillin is a novel beta-lactam antibiotic with potential therapeutic applications.

    Purpose of the Study:

    • To evaluate the therapeutic efficacy and safety of temocillin in critically ill patients.
    • To assess temocillin's effectiveness against a range of bacterial pathogens implicated in serious infections.

    Main Methods:

    • A study involving 30 critically ill patients with various severe infections.
    • Patients received temocillin 1g intravenously twice daily.
    • Pathogen identification and sensitivity testing were performed.

    Main Results:

    • Temocillin demonstrated high efficacy in 21 out of 22 patients with peritonitis.
    • Effectiveness was also noted in 6 out of 8 patients with long-lasting infections caused by sensitive pathogens.
    • No adverse reactions to temocillin were reported in any patient.

    Conclusions:

    • Temocillin is an effective and safe therapeutic option for severe bacterial infections in critically ill patients.
    • Its efficacy against pathogens like Escherichia coli and Proteus is notable.
    • Further consideration of temocillin for patients undergoing abdominal surgery is warranted.

    Related Experiment Videos